1. Aghajanian, G. K., Roth, R. H.: ?-Hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy. J. Pharmacol. exp. Ther. 175, 131?138 (1970)
2. And�n, N. E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 89?92 (1973)
3. And�n, N. E., Wachtel, H.: Biochemical effects of baclofen (?-parachlorophenyl-GABA) on the dopamine and noradrenaline in the rat brain. Acta pharmacol. (Kbh.) 40, 310?320 (1977)
4. Beleslin, D. B., Samardzic, R.: Failure of autonomic and central nervous system blocking agents to antagonize the groos behavioural effects of tubocurarine injected intraventricularly in conscious cats. J. Pharm. Pharmacol. 28, 519 (1976)
5. Breese, G. R., Cooper, B. R., Prange, A. J., Cott, J. M., Lipton, M. A.: Interactions of thyrotropin-releasing hormone with centrally acting drugs. In: The thyroid axis, drugs and behavior, A. J. Prange, ed., pp. 115?127. New York: Raven Press 1974a